TNXP
Price:
$0.4031
Market Cap:
$75.34M
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Its rare disease portfolio comprises...[Read more]
Industry
Biotechnology
IPO Date
2012-05-10
Stock Exchange
NASDAQ
Ticker
TNXP
According to Tonix Pharmaceuticals Holding Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -92.67% compared to the average of -0.14 of the last 4 quarters.
The mean historical PE Ratio of Tonix Pharmaceuticals Holding Corp. over the last ten years is -0.28. The current -0.01 PE Ratio has changed 255.01% with respect to the historical average. Over the past ten years (40 quarters), TNXP's PE Ratio was at its highest in in the December 2014 quarter at 0. The PE Ratio was at its lowest in in the September 2022 quarter at -6.31.
Average
-0.28
Median
0
Minimum
-1.41
Maximum
0
Discovering the peaks and valleys of Tonix Pharmaceuticals Holding Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = -1.41
Year | PE Ratio | Change |
---|---|---|
2023 | -0.06 | -51.64% |
2022 | -0.12 | -91.38% |
2021 | -1.41 | 15.41% |
2020 | -1.22 | -Infinity% |
2019 | 0 | 0% |
2018 | 0 | 0% |
2017 | 0 | 0% |
2016 | 0 | 0% |
2015 | 0 | 0% |
2014 | 0 | 0% |
The current PE Ratio of Tonix Pharmaceuticals Holding Corp. (TNXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.53
5-year avg
-0.56
10-year avg
-0.28
Tonix Pharmaceuticals Holding Corp.’s PE Ratio is greater than Sonnet BioTherapeutics Holdings, Inc. (-0.18), greater than Onconova Therapeutics, Inc. (-0.09), greater than Palisade Bio, Inc. (-0.19), greater than iBio, Inc. (-0.88), greater than Jaguar Health, Inc. (-0.24), greater than Acasti Pharma Inc. (-3.10), greater than Diffusion Pharmaceuticals Inc. (-1.61), greater than Vaxart, Inc. (-1.89), greater than VBI Vaccines Inc. (-0.02), greater than Bright Minds Biosciences Inc. (-69.67), greater than Virax Biolabs Group Limited (-0.64), greater than Novavax, Inc. (-4.85), less than Inovio Pharmaceuticals, Inc. (-0.00), greater than Enveric Biosciences, Inc. (-0.27), greater than CohBar, Inc. (-0.13),
Company | PE Ratio | Market cap |
---|---|---|
-0.18 | $4.33M | |
-0.09 | $20.90M | |
-0.19 | $4.84M | |
-0.88 | $21.59M | |
-0.24 | $11.52M | |
-3.10 | $34.17M | |
-1.61 | $8.98M | |
-1.89 | $136.76M | |
-0.02 | $1.87M | |
-69.67 | $268.84M | |
-0.64 | $8.34M | |
-4.85 | $1.38B | |
-0.00 | $64.62M | |
-0.27 | $3.15M | |
-0.13 | $1.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tonix Pharmaceuticals Holding Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tonix Pharmaceuticals Holding Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tonix Pharmaceuticals Holding Corp.'s PE Ratio?
How is the PE Ratio calculated for Tonix Pharmaceuticals Holding Corp. (TNXP)?
What is the highest PE Ratio for Tonix Pharmaceuticals Holding Corp. (TNXP)?
What is the 3-year average PE Ratio for Tonix Pharmaceuticals Holding Corp. (TNXP)?
What is the 5-year average PE Ratio for Tonix Pharmaceuticals Holding Corp. (TNXP)?
How does the current PE Ratio for Tonix Pharmaceuticals Holding Corp. (TNXP) compare to its historical average?